Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours
Condition(s):Solid TumorLast Updated:November 28, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Solid TumorLast Updated:November 28, 2011Completed
Condition(s):Hodgkin’s LymphomaLast Updated:May 11, 2021Completed
Condition(s):Hodgkin’s LymphomaLast Updated:January 27, 2022Terminated
Condition(s):MelanomaLast Updated:December 14, 2015Completed
Condition(s):Cervical Cancer; Cervix Cancer; Cervix NeoplasmLast Updated:December 7, 2020Unknown status
Condition(s):Melanoma; Skin NeoplasmsLast Updated:October 17, 2018Unknown status
Condition(s):Recurrent Plasma Cell MyelomaLast Updated:June 15, 2021Completed
Condition(s):Lymphoma, T-Cell, CutaneousLast Updated:November 3, 2016Completed
Condition(s):Graft-Versus-Host DiseaseLast Updated:May 15, 2018Completed
Condition(s):HIV InfectionsLast Updated:February 13, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.